Brief: Kopran Says No 483 Observations Issued By USFDA After Inspection Of Co's Madad Facility
25/01/2019 09:58
Jan 25 (Reuters) - Kopran Ltd KPRN.NS :
* KOPRAN - API MANUFACTURING FACILITY AT MADAD OF UNIT
INSPECTED
BY THE US FDA FROM JAN 21 TO JAN 25
* KOPRAN - INSPECTION COMPLETED WITHOUT ISSUANCE OF
OBSERVATION
UNDER 483
Source text - https://bit.ly/2Wfa3DD
Further company coverage: KPRN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kopran
See all newsBrief: Kopran Says EU Medicine Authority Conducts GMP Inspection At Khopran Khopoli Facility Sept 18-23, 2026
Brief: Kopran June-Quarter Consol Profit 67 Million Rupees
India's Kopran rises as quarterly profit nearly doubles
Brief: Kopran March-Quarter Consol Net Profit 188.7 Million Rupees
Brief: Kopran Flags Cyber-Attack At Its Khopoli Factory